Status:
COMPLETED
Study to Identify if OVR Health's VR-Kit is Safe to Use and Helps to Improve Focus, Attention and Reduce Worry & Rumination.
Lead Sponsor:
Oxford VR
Collaborating Sponsors:
Citruslabs
Conditions:
Anxiety
Depression, Anxiety
Eligibility:
All Genders
18-79 years
Phase:
NA
Brief Summary
This is a randomized-controlled interventional treatment study with three arms of comparable demographics to evaluate the safety and efficacy of OVR Health's VR experience to improve control over the ...
Eligibility Criteria
Inclusion
- Male or female over 18 years old
- Must be in good general health
- Self-reported with the following symptoms (as assessed by questions and questionnaires in study material):
- Finding it hard to let go of difficult thoughts.
- Looking out for signs of a potential threat in their environment (or in their body) that unhelpfully maintains their problem.
- Engaging in repetitive, unhelpful patterns of negative thinking (worry \& rumination). • These may be due to a diagnosis of a mental health condition, but this is not required for entry into the study.
- Good understanding of written and spoken English
- Willing and able to give informed consent
- Willing and able to follow the study protocol
- Willing and able to use VR headset at home
- WiFi connection to connect VR headset at home
- Willing and able to return VR headset
Exclusion
- Current diagnosis of epilepsy, dementia, or another neurological disease that may prevent the use of VR hardware and software
- Individuals with suicidal or self-harm thoughts
- Significant visual, auditory, or balance impairment
- Insufficient comprehension of English
- Primary diagnosis of alcohol or substance abuse disorder, or personality disorder • Significant learning disability
- Current active suicidal plans or self-harm (in which case participant will be referred to appropriate crisis service)
- Receiving current alternative psychotherapy treatment
- Unwilling to provide consent
- Unwilling to follow the study protocol
Key Trial Info
Start Date :
February 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 15 2021
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05291429
Start Date
February 15 2021
End Date
July 15 2021
Last Update
March 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Citruslabs
Santa Monica, California, United States, 90404